The synthesis of [1-deamino,4-l-leucine]-oxytocin and [1-deamino,4-l-isoleucine]-oxytocin and some of their pharmacological properties

Herbert Takashima, Victor J Hruby, Vincent Du Vigneaud

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

[1-Deamino,4-L-leucine]-oxytocin and [1-deamino,4-L-isoleucine]-oxytocin have been synthesized by the solid phase method, and some of their pharmacological properties have been determined. [1-Deamino,4-L-leucine]-oxytocin was also synthesized by the p-nitrophenyl ester stepwise procedure and compared to that synthesized by the solid phase method. The two preparations were found to be identical. The oxytocic and avian vasodepressor potencies of [1-deamino,4-L-leucine]-oxytocin and [1-deamino,4-L-isoleucine]-oxytocin are two- to three-fold higher than those of [4-L-leucine]-oxytocin and [4-L-isoleucine]-oxytocin respectively. The two deamino analogs also exhibit milk-ejecting activities of approximately 150 units/mg. Neither analog possesses appreciable pressor or antidiuretic activity. A similar enhancement of oxytocic and avian vasodepressor activities had been observed when the free amino group of [4-L-valine]-oxytocin was replaced by hydrogen.

Original languageEnglish (US)
Pages (from-to)677-680
Number of pages4
JournalJournal of the American Chemical Society
Volume92
Issue number3
StatePublished - 1970
Externally publishedYes

Fingerprint

Isoleucine
Oxytocin
Leucine
Pharmacology
Esters
Oxytocics
Hydrogen
Valine
Milk

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

The synthesis of [1-deamino,4-l-leucine]-oxytocin and [1-deamino,4-l-isoleucine]-oxytocin and some of their pharmacological properties. / Takashima, Herbert; Hruby, Victor J; Vigneaud, Vincent Du.

In: Journal of the American Chemical Society, Vol. 92, No. 3, 1970, p. 677-680.

Research output: Contribution to journalArticle

@article{aa1719d8862a4fce900fe297f27b4699,
title = "The synthesis of [1-deamino,4-l-leucine]-oxytocin and [1-deamino,4-l-isoleucine]-oxytocin and some of their pharmacological properties",
abstract = "[1-Deamino,4-L-leucine]-oxytocin and [1-deamino,4-L-isoleucine]-oxytocin have been synthesized by the solid phase method, and some of their pharmacological properties have been determined. [1-Deamino,4-L-leucine]-oxytocin was also synthesized by the p-nitrophenyl ester stepwise procedure and compared to that synthesized by the solid phase method. The two preparations were found to be identical. The oxytocic and avian vasodepressor potencies of [1-deamino,4-L-leucine]-oxytocin and [1-deamino,4-L-isoleucine]-oxytocin are two- to three-fold higher than those of [4-L-leucine]-oxytocin and [4-L-isoleucine]-oxytocin respectively. The two deamino analogs also exhibit milk-ejecting activities of approximately 150 units/mg. Neither analog possesses appreciable pressor or antidiuretic activity. A similar enhancement of oxytocic and avian vasodepressor activities had been observed when the free amino group of [4-L-valine]-oxytocin was replaced by hydrogen.",
author = "Herbert Takashima and Hruby, {Victor J} and Vigneaud, {Vincent Du}",
year = "1970",
language = "English (US)",
volume = "92",
pages = "677--680",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - The synthesis of [1-deamino,4-l-leucine]-oxytocin and [1-deamino,4-l-isoleucine]-oxytocin and some of their pharmacological properties

AU - Takashima, Herbert

AU - Hruby, Victor J

AU - Vigneaud, Vincent Du

PY - 1970

Y1 - 1970

N2 - [1-Deamino,4-L-leucine]-oxytocin and [1-deamino,4-L-isoleucine]-oxytocin have been synthesized by the solid phase method, and some of their pharmacological properties have been determined. [1-Deamino,4-L-leucine]-oxytocin was also synthesized by the p-nitrophenyl ester stepwise procedure and compared to that synthesized by the solid phase method. The two preparations were found to be identical. The oxytocic and avian vasodepressor potencies of [1-deamino,4-L-leucine]-oxytocin and [1-deamino,4-L-isoleucine]-oxytocin are two- to three-fold higher than those of [4-L-leucine]-oxytocin and [4-L-isoleucine]-oxytocin respectively. The two deamino analogs also exhibit milk-ejecting activities of approximately 150 units/mg. Neither analog possesses appreciable pressor or antidiuretic activity. A similar enhancement of oxytocic and avian vasodepressor activities had been observed when the free amino group of [4-L-valine]-oxytocin was replaced by hydrogen.

AB - [1-Deamino,4-L-leucine]-oxytocin and [1-deamino,4-L-isoleucine]-oxytocin have been synthesized by the solid phase method, and some of their pharmacological properties have been determined. [1-Deamino,4-L-leucine]-oxytocin was also synthesized by the p-nitrophenyl ester stepwise procedure and compared to that synthesized by the solid phase method. The two preparations were found to be identical. The oxytocic and avian vasodepressor potencies of [1-deamino,4-L-leucine]-oxytocin and [1-deamino,4-L-isoleucine]-oxytocin are two- to three-fold higher than those of [4-L-leucine]-oxytocin and [4-L-isoleucine]-oxytocin respectively. The two deamino analogs also exhibit milk-ejecting activities of approximately 150 units/mg. Neither analog possesses appreciable pressor or antidiuretic activity. A similar enhancement of oxytocic and avian vasodepressor activities had been observed when the free amino group of [4-L-valine]-oxytocin was replaced by hydrogen.

UR - http://www.scopus.com/inward/record.url?scp=0014940963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0014940963&partnerID=8YFLogxK

M3 - Article

C2 - 5460748

AN - SCOPUS:0014940963

VL - 92

SP - 677

EP - 680

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 3

ER -